Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice-Reference-Cited by-同舟云学术

Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice

Published:2023-10-26 Issue:11 Volume:20 Page:5877-5887
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Biali Myriam El¹,Auvity Sylvain²³,Cisternino Salvatore²³,Smirnova Maria²,Hacker Marcus⁴,Zeitlinger Markus¹,Mairinger Severin¹⁴,Tournier Nicolas⁵,Bauer Martin¹,Langer Oliver¹⁴^ORCID

Affiliation:

1. Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria

2. Inserm UMRS1144, Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Cité, F-75006 Paris, France

3. Service Pharmacie, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire-Necker-Enfants Malades, F-75015 Paris, France

4. Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, 1090 Vienna, Austria

5. Laboratoire d’Imagerie Biomédicale Multimodale (BioMaps), CEA, CNRS, Inserm, Service Hospitalier Frédéric Joliot, Université Paris-Saclay, 91401 Orsay, France

Funder

Austrian Science Fund

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00715

Reference53 articles.

1. The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?

2. Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions

3. A comprehensive insight on ocular pharmacokinetics

4. Roles of Drug Transporters in Blood-Retinal Barrier

5. Selective drug delivery to the retinal cells: Biological barriers and avenues